Mersana Therapeutics (MRSN) Q2 2025 Earnings

15MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-4.81
-3.24
-1.66
-0.09

Details

Expected EPS
-4.813929
Actual EPS
-4.75
Surprise EPS
0.06
Surprise Percent
+1.33%

Description

Mersana Therapeutics (MRSN) has reported earnings of -4.75 per share for Q2 2025.

0 Comments

Share your thoughts